Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Vaccinations01:51

Vaccinations

Overview
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Mucosal Type II Interferon Limits SARS-CoV-2 Replication in Humans.

medRxiv : the preprint server for health sciences·2026
Same author

Bioactive enhanced adjuvant chemokine oligonucleotide nanoparticles (BEACONs) for mucosal vaccination against genital herpes.

Science immunology·2026
Same author

Analysis Of Salivary Herpesviruses Reveals Associations Between HHV-6 And Long COVID Severity.

medRxiv : the preprint server for health sciences·2026
Same author

A causal link between autoantibodies and neurological symptoms in long COVID.

Cell·2026
Same author

Freedom of scientific inquiry: reclaiming space for controversy.

Nature reviews. Immunology·2026
Same author

Intranasal Anti-CD3 Antibody Treatment Attenuates Post-COVID Neuroinflammation and Enhances Hippocampal Neurogenesis and Cognitive Function in Mice.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: May 8, 2026

Isolation of Lymphocytes from Mouse Genital Tract Mucosa
04:46

Isolation of Lymphocytes from Mouse Genital Tract Mucosa

Published on: September 3, 2012

Generating protective immunity against genital herpes.

Haina Shin1, Akiko Iwasaki

  • 1Howard Hughes Medical Institute, Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.

Trends in Immunology
|September 10, 2013
PubMed
Summary

Genital herpes is a chronic infection. New vaccine strategies are needed to prevent transmission and clear the herpes simplex virus (HSV) infection, as current antivirals are insufficient.

Keywords:
antibodiescell migrationfemale genital tractmemory T cellsprotective immunityvaccines

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
07:27

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

Related Experiment Videos

Last Updated: May 8, 2026

Isolation of Lymphocytes from Mouse Genital Tract Mucosa
04:46

Isolation of Lymphocytes from Mouse Genital Tract Mucosa

Published on: September 3, 2012

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
07:27

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Genital herpes, caused by herpes simplex virus (HSV), is a prevalent, incurable chronic condition.
  • It causes recurrent painful symptoms and increases susceptibility to other STIs like HIV-1.
  • Current antiviral treatments do not prevent viral shedding or transmission.

Purpose of the Study:

  • To review recent advancements in understanding host responses to HSV infection.
  • To discuss the history and outcomes of past clinical vaccine trials for genital herpes.
  • To highlight novel strategies for developing effective genital herpes vaccines.

Main Methods:

  • Review of current literature on host immunity against HSV.
  • Analysis of data from completed and ongoing clinical trials of HSV vaccines.
  • Exploration of emerging vaccine technologies and therapeutic approaches.

Main Results:

  • Recent studies offer improved insights into host immune mechanisms against HSV.
  • Past clinical trials have faced challenges, indicating a need for refined vaccine designs.
  • New vaccine strategies show promise in preclinical and early clinical investigations.

Conclusions:

  • An effective vaccine is critical for controlling the spread of genital herpes.
  • Understanding host responses is key to designing successful HSV vaccines.
  • Innovative approaches are essential to overcome challenges in genital herpes vaccine development.